|Articles|November 29, 2016
SCRS Welcomes Roche as a New Global Impact Partner
The Society for Clinical Research Sites (SCRS) announces that Roche has become a Global Impact Partner (GIP).
Advertisement
The Society for Clinical Research Sites (SCRS) announces that Roche has become a Global Impact Partner (GIP). Through this partnership, Roche will serve on the SCRS Global Impact Board and work closely with the organization’s Leadership Council working toward strategic initiatives.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
